UniProt ID | MDFIC_HUMAN | |
---|---|---|
UniProt AC | Q9P1T7 | |
Protein Name | MyoD family inhibitor domain-containing protein | |
Gene Name | MDFIC {ECO:0000312|HGNC:HGNC:28870} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 246 | |
Subcellular Localization |
Isoform 1: Nucleus, nucleolus. Also shows a granular distribution in the cytoplasm. Isoform 2: Cytoplasm . Weak expression in the nucleus. |
|
Protein Description | Acts as a transcriptional activator or repressor. Inhibits the transcriptional activation of Zic family proteins ZIC1, ZIC2 and ZIC3. Retains nuclear Zic proteins ZIC1, ZIC2 and ZIC3 in the cytoplasm. Modulates the expression from both cellular and viral promoters. Down-regulates Tat-dependent transcription of the human immunodeficiency virus type 1 (HIV-1) LTR by interacting with HIV-1 Tat and Rev and impairing their nuclear import, probably by rendering the NLS domains inaccessible to importin-beta. Also stimulates activation of human T-cell leukemia virus type I (HTLV-I) LTR. Binds to the axin complex, resulting in an increase in the level of free beta-catenin. Affects axin regulation of the WNT and JNK signaling pathways.. | |
Protein Sequence | MSGAGEALAPGPVGPQRVAEAGGGQLGSTAQGKCDKDNTEKDITQATNSHFTHGEMQDQSIWGNPSDGELIRTQPQRLPQLQTSAQVPSGEEIGKIKNGHTGLSNGNGIHHGAKHGSADNRKLSAPVSQKMHRKIQSSLSVNSDISKKSKVNAVFSQKTGSSPEDCCVHCILACLFCEFLTLCNIVLGQASCGICTSEACCCCCGDEMGDDCNCPCDMDCGIMDACCESSDCLEICMECCGICFPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 (in isoform 1) | Phosphorylation | - | 5.27 | - | |
15 (in isoform 1) | Phosphorylation | - | 21.02 | - | |
18 (in isoform 1) | Phosphorylation | - | 4.80 | 18767875 | |
18 | Phosphorylation | GPVGPQRVAEAGGGQ CCCCHHHHHHCCCCC | 4.80 | 18767875 | |
28 | Phosphorylation | AGGGQLGSTAQGKCD CCCCCCCCCCCCCCC | 29.21 | - | |
29 | Phosphorylation | GGGQLGSTAQGKCDK CCCCCCCCCCCCCCC | 22.62 | - | |
33 | Ubiquitination | LGSTAQGKCDKDNTE CCCCCCCCCCCCCCC | 27.46 | 33845483 | |
89 | Phosphorylation | QTSAQVPSGEEIGKI CCCCCCCCHHHHCCC | 61.04 | 28555341 | |
95 | Ubiquitination | PSGEEIGKIKNGHTG CCHHHHCCCCCCCCC | 57.05 | 33845483 | |
117 | Phosphorylation | HHGAKHGSADNRKLS CCCCCCCCCCCCCCC | 31.97 | 29514088 | |
122 | Ubiquitination | HGSADNRKLSAPVSQ CCCCCCCCCCCCHHH | 53.71 | 29967540 | |
124 | Phosphorylation | SADNRKLSAPVSQKM CCCCCCCCCCHHHHH | 33.30 | 25159151 | |
128 | Phosphorylation | RKLSAPVSQKMHRKI CCCCCCHHHHHHHHH | 24.03 | 29255136 | |
130 | Ubiquitination | LSAPVSQKMHRKIQS CCCCHHHHHHHHHHH | 29.21 | 32015554 | |
134 | Ubiquitination | VSQKMHRKIQSSLSV HHHHHHHHHHHHHCC | 30.34 | 33845483 | |
137 | Phosphorylation | KMHRKIQSSLSVNSD HHHHHHHHHHCCCCC | 36.40 | 30108239 | |
138 | Phosphorylation | MHRKIQSSLSVNSDI HHHHHHHHHCCCCCC | 14.32 | 30108239 | |
140 | Phosphorylation | RKIQSSLSVNSDISK HHHHHHHCCCCCCCH | 22.62 | 30266825 | |
142 | Ubiquitination | IQSSLSVNSDISKKS HHHHHCCCCCCCHHH | 30.50 | 33845483 | |
143 | Phosphorylation | QSSLSVNSDISKKSK HHHHCCCCCCCHHHH | 33.88 | 30266825 | |
146 | Phosphorylation | LSVNSDISKKSKVNA HCCCCCCCHHHHHEE | 38.73 | 30266825 | |
147 | Ubiquitination | SVNSDISKKSKVNAV CCCCCCCHHHHHEEE | 62.49 | 33845483 | |
147 | Acetylation | SVNSDISKKSKVNAV CCCCCCCHHHHHEEE | 62.49 | 19819213 | |
148 | Acetylation | VNSDISKKSKVNAVF CCCCCCHHHHHEEEE | 49.03 | 19819221 | |
149 | Phosphorylation | NSDISKKSKVNAVFS CCCCCHHHHHEEEEC | 45.64 | 24719451 | |
150 | Ubiquitination | SDISKKSKVNAVFSQ CCCCHHHHHEEEECC | 48.68 | 29967540 | |
204 | Ubiquitination | SEACCCCCGDEMGDD CCCCCCCCCCCCCCC | 4.86 | 33845483 | |
231 | Ubiquitination | DACCESSDCLEICME HHHCCCCHHHHHHHH | 50.75 | 29967540 | |
239 | Ubiquitination | CLEICMECCGICFPS HHHHHHHHHCCCCCC | 0.74 | 32015554 | |
243 | Ubiquitination | CMECCGICFPS---- HHHHHCCCCCC---- | 2.20 | 33845483 | |
249 | Phosphorylation | ICFPS---------- CCCCC---------- | 19651622 | ||
252 | Phosphorylation | PS------------- CC------------- | 19651622 | ||
255 | Phosphorylation | ---------------- ---------------- | 18578522 | ||
256 | Ubiquitination | ----------------- ----------------- | 33845483 | ||
259 | Ubiquitination | -------------------- -------------------- | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MDFIC_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MDFIC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MDFIC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CCNT1_HUMAN | CCNT1 | physical | 12944466 | |
MDFIC_HUMAN | MDFIC | physical | 12944466 | |
CDK9_HUMAN | CDK9 | physical | 12944466 | |
TAT_HV1H2 | tat | physical | 12944466 | |
KS6A5_HUMAN | RPS6KA5 | physical | 21988832 | |
SOCS4_HUMAN | SOCS4 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-143, ANDMASS SPECTROMETRY. |